Sort
30,917 grants matching “tumor microenvironment”
SPORE Core 1: Administrative, Evaluation and Planning
$270,189Wayne A. Marasco · Brigham And Women'S Hospital · P50 · FY2011 · CA
Project 3: HHLA2 as a THerapeutic Target in RCC
$270,115David McDermott · Beth Israel Deaconess Medical Center · P50 · FY2020 · CA
The molecular regulation of IGFBP-3 in esophageal epthelial cells
$270,113Hiroshi Nakagawa · University Of Pennsylvania · R01 · FY2008 · DK
The molecular regulation of IGFBP-3 in esophageal epthelial cells
$270,113Hiroshi Nakagawa · University Of Pennsylvania · R01 · FY2009 · DK
Role of IKK in NSCLC: Modulation of SMRT and NF-kappaB
$270,040Marty W Mayo · University Of Virginia · R01 · FY2011 · CA
Role of IKK in NSCLC: Modulation of SMRT and NF-kappaB
$270,040Marty W Mayo · University Of Virginia · R01 · FY2012 · CA
Antitumor Mechanisms of anti-CD40/CpG-activated Macrophages
$270,001Paul M Sondel · University Of Wisconsin-Madison · R01 · FY2009 · CA
Antitumor Mechanisms of anti-CD40/CpG-activated Macrophages
$270,001Paul M Sondel · University Of Wisconsin-Madison · R01 · FY2010 · CA
Antitumor Mechanisms of anti-CD40/CpG-activated Macrophages
$270,001Paul M Sondel · University Of Wisconsin-Madison · R01 · FY2008 · CA
Vitamin D in Prostate Cancer: Tumor Vasculature Effects
$270,000Candace S Johnson · Roswell Park Cancer Institute Corp · R01 · FY2008 · CA
Development of Molecularly Targeted Imaging Agents for Early Detection of PDAC
$270,000Kimberly A. Kelly · University Of Virginia · R01 · FY2008 · CA
Notch as a New Therapeutic Target in Hematological Malignancies
$269,999Yulia Nefedova · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2008 · CA
Spatial and Bayesian modeling methods for assessment of the tumor immune microenvironment and survival of women with ovarian cancer
$269,992Brooke L Fridley · Children'S Mercy Hosp (Kansas City, Mo) · R01 · FY2023 · CA
Project 1: Targeting Metastatic Prostate Cancer Patients with Biallelic Loss of CDK12
$269,895Arul M Chinnaiyan · University Of Michigan At Ann Arbor · P50 · FY2020 · CA
Dynamic Magnetic Targeting of Activated Brain Macrophages for Glioma Therapy
$269,889Behnam Badie · Beckman Research Institute/City Of Hope · R21 · FY2013 · NS
Role of Fibulin-5 in Tumorigenesis and TGF-beta Biology
$269,848National Jewish Health · R01 · FY2005 · CA
Role of Fibulin-5 in Tumorigenesis and TGF-beta Biology
$269,848National Jewish Health · R01 · FY2004 · CA
Mesenchymal Derived Growth Factors in Prostatic Cancer
$269,842David R Rowley · Baylor College Of Medicine · R01 · FY2009 · CA
Mesenchymal Derived Growth Factors in Prostatic Cancer
$269,842David R Rowley · Baylor College Of Medicine · R01 · FY2010 · CA
NMR Monitoring of Temperature and Its Biological Effects
$269,839Navin Bansal · Indiana University Indianapolis · R33 · FY2008 · CA
Project 3: Neoplastic Cell Evolution
$269,814Darryl K Shibata · Arizona State University-Tempe Campus · U54 · FY2021 · CA
Regulation of Fibronectin Matrix Assembly by uPAR
$269,742Paula J Mc Keown-Longo · Albany Medical College · R01 · FY2008 · CA
Biomarker Identification to Increase Adjunctive Cryoablation and Checkpoint-Inhibitor Immunotherapy Response
$269,684Eric Wehrenberg-Klee · Massachusetts General Hospital · K08 · FY2024 · CA
Biomarker Identification to Increase Adjunctive Cryoablation and Checkpoint-Inhibitor Immunotherapy Response
$269,684Eric Wehrenberg-Klee · Massachusetts General Hospital · K08 · FY2023 · CA
Biomarker Identification to Increase Adjunctive Cryoablation and Checkpoint-Inhibitor Immunotherapy Response
$269,684Eric Wehrenberg-Klee · Massachusetts General Hospital · K08 · FY2020 · CA